STOCK2S-26016 [332922-63-1]

TargetMol Chemicals

STOCK2S-26016 [332922-63-1]

72

332922-63-1

Research Use Only

STOCK2S-26016

C20H19N3O2

333.38

WNK-IN-B is an inhibitor of Wnk signalling. WNK-IN-B is a cell-permeable diaminoacridine derivative that targets the CCT domain of SPAK and OSR1 via reversible binding. WNK-IN-B selectively suppress hypotonic shock-induced WNK signaling pathway activation in mpkDCT and MOVAS (100 microM) cultures without affecting p38 MAPK phosphorylation.

3 years

NC=1C2=C(N=C3C1C=C(OCC)C=C3)C=C(NCC4=CC=CO4)C=C2

-20°C

12352200